Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Pharma Services154K87.50%
Laboratory developed test services22K12.50%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States - Pharma Services886.77K59.00%
Outside of the United States - Pharma Services586.17K39.00%
United States - Laboratory developed test services30.06K2.00%
